Flyuanksol (international name - Flupentixol) refers to a group of antipsychotic drugs which have
antidepressant, sedative and anxiolytic effects.
Good reviews Flyuanksol was due to the effective activation of the emotional state of patients and facilitate their social adaptation.
Structure and Composition
The main active ingredient - flupenthixol hydrochloride 4 mg.
Flyuanksol available as a solution for intramuscular injection (oil-based), and 5 mg tablet, placed in a carton 50-100 pcs.
Pharmacological properties Flyuanksola
Flyuanksol is a neuroleptic which blocks dopamine receptors in the brain and adrenergic receptors. As a result of sedation flupenthixol achieved within 7 days of regular ingestion.
Good reviews Flyuanksol is like a drug, quickly eliminates the symptoms of depression, psychosis and contribute to the restoration of thinking. Patients with antisocial disorders gradually adapt to society and become sociable.
Flyuanksol rapidly absorbed, reaching maximum concentrations within 4-7 hours. Bioavailability is 40-42%. The drug forms several inactive metabolites and excreted in the faeces and urine.
The drug enhances the effect of sedatives, ethanol and drugs which depress the nervous system. At simultaneous reception Flyuanksola and guanethidine reduced therapeutic effect.
Interaction Flyuanksola and piperazine increases the risk of adverse reactions, as well as contributes to the emergence of extrapyramidal disorders.
Flyuanksol prescribed for the treatment of psychotic states with hallucinations and paranoid symptoms, disturbances in thinking, apathy, social adaptation disorders, autism, schizophrenia, psychoses of different etiology, stress, depression, neurosis.
Positive feedback received Flyuanksol as an effective drug for the treatment of psychosomatic disorders and eliminate the effects of fetal alcohol syndrome.
Instructions for use Flyuanksola
According to the instructions Flyuanksol in the form of tablets to be taken into 1-2 times a day for 0, 5-1 mg. On the recommendation of the attending physician, the dosage may be increased to 1 mg 3 times a day. In the absence of therapeutic action within 7-10 days of medication overturned.
In severe psychotic disorders Flyuanksol appoint 3-10 mg 3 times a day. The maximum daily dose for acute psychosis should not exceed 100 mg. Maintenance dose is 5-20 mg 1-2 times a day for 5 days and then the dosage is gradually decreased to 3 mg 1 time per day.
Instructions Flyuanksola prescribes a solution for intramuscular injection of 20-40 ml of 1 times per day. The course of treatment is 2-3 weeks. The maintenance dose is 20 ml of 1 times per day at intervals of 2-4 days. In recurrent mental illness, the dosage may be increased to 400 mg per day. When you go to other antipsychotic drugs should be gradually reduce the dosage Flyuanksola.
In accordance with the instructions Flyuanksola during treatment should use caution or temporarily suspend their activities for patients who are driving a vehicle and work in production. Flyuanksol may reduce attention and psychomotor slow down the reaction.
Contraindications to the appointment
Flyuanksola are hypersensitivity and intolerance to the components of the drug, a bone marrow disease, circulatory disorders, collapse, coma, pregnancy and breastfeeding, glaucoma, kidney and liver failure, Parkinson's disease, fever, Reye's syndrome, children under 16 years.
With caution and under constant supervision of the physician medication prescribed for alcoholism, diseases of the circulatory system, peptic ulcer disease, infectious disease, severe lung disease, hepatitis, and in old age.
Side effects Flyuanksola
Flyuanksol may cause the following side effects:
- the central nervous system - insomnia, drowsiness, anxiety, tremors, collapse, headache, dizziness, loss of coordination, dyskinesia;
- on the part of the cardiovascular system - tachycardia, arrhythmia, hypotension;
- on the part of the digestive system - diarrhea, dyspepsia, vomiting, nausea, constipation, flatulence, hepatitis;
- From the senses - clouding of the lens, hearing impairment, glaucoma, reduced visual acuity;
- on the part of the circulatory system - leukopenia, anemia;
- on the part of the endocrine system - diabetes, dysmenorrhea, gynecomastia, carbohydrate metabolism;
- allergic reaction - hives, dermatitis, bronchospasm, flushing of the skin, increased sensitivity to light.